EP0500893A4 - Preservation of blood, tissues and biological fluids - Google Patents

Preservation of blood, tissues and biological fluids

Info

Publication number
EP0500893A4
EP0500893A4 EP19910916527 EP91916527A EP0500893A4 EP 0500893 A4 EP0500893 A4 EP 0500893A4 EP 19910916527 EP19910916527 EP 19910916527 EP 91916527 A EP91916527 A EP 91916527A EP 0500893 A4 EP0500893 A4 EP 0500893A4
Authority
EP
European Patent Office
Prior art keywords
blood
tissues
preservation
biological fluids
fluids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910916527
Other languages
French (fr)
Other versions
EP0500893A1 (en
Inventor
Edward Shanbrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0500893A1 publication Critical patent/EP0500893A1/en
Publication of EP0500893A4 publication Critical patent/EP0500893A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0236—Mechanical aspects
    • A01N1/0263—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving, e.g. cool boxes, blood bags or "straws" for cryopreservation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0289—Pressure processes, i.e. using a designated change in pressure over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Mechanical Engineering (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Charge And Discharge Circuits For Batteries Or The Like (AREA)

Abstract

The treatment and preservation of blood, blood derivatives and other body tissues, fluids and cells with povidone-iodine to kill pathogenic microbes without destroying the utility of the tissues, fluids and cells is disclosed.
EP19910916527 1990-09-04 1991-09-03 Preservation of blood, tissues and biological fluids Withdrawn EP0500893A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57720490A 1990-09-04 1990-09-04
US577204 1990-09-04

Publications (2)

Publication Number Publication Date
EP0500893A1 EP0500893A1 (en) 1992-09-02
EP0500893A4 true EP0500893A4 (en) 1993-03-10

Family

ID=24307713

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910916527 Withdrawn EP0500893A4 (en) 1990-09-04 1991-09-03 Preservation of blood, tissues and biological fluids

Country Status (5)

Country Link
EP (1) EP0500893A4 (en)
JP (1) JPH05502183A (en)
AU (1) AU644216B2 (en)
CA (1) CA2072871A1 (en)
WO (1) WO1992004031A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370869A (en) * 1990-09-04 1994-12-06 Shanbrom; Edward Antimicrobial preservation of platelets and blood factors
US5333626A (en) * 1991-12-31 1994-08-02 Cryolife, Inc. Preparation of bone for transplantation
US5513662A (en) * 1991-12-31 1996-05-07 Osteotech, Inc. Preparation of bone for transplantation
JPH06509118A (en) * 1992-05-04 1994-10-13 シャンブロム、エドワード safe biofluids
EP0605704A4 (en) * 1992-06-29 1994-11-17 Edward Shanbrom Starch-iodine-peroxide preservation of blood, tissues and biological fluids.
JPH06510798A (en) * 1992-06-29 1994-12-01 シャンブロム、エドワード Preservation of Blood, Tissues and Biofluids with Povidone Hydrogen Peroxide
DE4343226A1 (en) * 1993-12-17 1995-06-22 Schenk Filterbau Gmbh Depth filter for killing microorganisms and inactivating viruses and their use
US5591350A (en) * 1994-04-15 1997-01-07 Pall Corporation Iodine disinfection method using a gaseous iodine treated porous medium
US6096216A (en) * 1994-06-09 2000-08-01 American National Red Cross Iodinated matrices for disinfecting biological fluids
US6114108A (en) * 1995-08-29 2000-09-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of viral nucleic acids
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
DE19544449A1 (en) 1995-11-29 1997-06-05 Basf Ag Powdered iodine complexes
US6352695B1 (en) 1997-10-03 2002-03-05 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6093564A (en) * 1997-10-03 2000-07-25 V.I. Technologies, Inc. Methods and compositions for the selective modification of nucleic acids
US6106773A (en) * 1998-09-24 2000-08-22 American National Red Cross Pathogen inactivating compositions for disinfecting biological fluids
US6617100B2 (en) 1998-09-25 2003-09-09 V.I. Technologies, Inc. Solid phase quenching systems
US6403359B1 (en) 1998-09-25 2002-06-11 V. I. TECHNOLOGIES, Inc. Solid phase quenching systems
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
WO2006093314A1 (en) * 2005-03-04 2006-09-08 National University Corporation, Tokyo Medical And Dental University Organ function maintaining and ameliorating solution
GB0707275D0 (en) * 2007-04-16 2007-05-23 Safemed Ltd Preservation composition
JP5379192B2 (en) * 2011-07-01 2013-12-25 エヌディー パートナーズ，リミティド ライアビリティー カンパニー Biocide lock
FR3072246B1 (en) 2017-10-13 2020-06-12 Biodesiv Efnium ANTIMICROBIAL POLYMER FOR ANIMAL SEEDS
CN109938008A (en) * 2019-03-20 2019-06-28 上海创宏生物科技有限公司 A kind of animal semen inorganic agent and its application method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079782A1 (en) * 1981-11-16 1983-05-25 Euroceltique S.A. Stabilized iodine-containing germicidal preparation
FR2529463A1 (en) * 1982-07-05 1984-01-06 Centre Nat Rech Scient METHOD AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR ALLOSTERIC EFFECTORS OF HEMOGLOBIN AND ERYTHROCYTES OBTAINED THEREBY
EP0259982A2 (en) * 1986-09-12 1988-03-16 Euroceltique S.A. Solid iodophor composition
EP0371283A2 (en) * 1988-11-30 1990-06-06 Euro-Celtique S.A. Stabilizing packaged iodophor and minimizing leaching of iodine through packaging
WO1990007876A1 (en) * 1989-01-19 1990-07-26 New York University Biological fluids purification systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2675341A (en) * 1949-12-28 1954-04-13 Gen Aniline & Film Corp Protein hydrolysate detoxified by polyvinyl pyrrolidone
US3169905A (en) * 1961-05-15 1965-02-16 William H Lambert Sanitizing composition and method of use
US3216579A (en) * 1961-05-25 1965-11-09 Ind Biology Lab Inc Water-insoluble polyvinylpyrrolidone composition
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
US3155590A (en) * 1962-08-02 1964-11-03 Ncr Co Encapsulation process and its product
AU639227B2 (en) * 1989-03-14 1993-07-22 David James Batten Improved method of treating footrot

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0079782A1 (en) * 1981-11-16 1983-05-25 Euroceltique S.A. Stabilized iodine-containing germicidal preparation
FR2529463A1 (en) * 1982-07-05 1984-01-06 Centre Nat Rech Scient METHOD AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR ALLOSTERIC EFFECTORS OF HEMOGLOBIN AND ERYTHROCYTES OBTAINED THEREBY
EP0259982A2 (en) * 1986-09-12 1988-03-16 Euroceltique S.A. Solid iodophor composition
EP0371283A2 (en) * 1988-11-30 1990-06-06 Euro-Celtique S.A. Stabilizing packaged iodophor and minimizing leaching of iodine through packaging
WO1990007876A1 (en) * 1989-01-19 1990-07-26 New York University Biological fluids purification systems

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 115, no. 22, 1990, Columbus, Ohio, US; abstract no. 239679h, SUZUKI ET AL. 'Quantitative evaluation of the inactivaton of human immunodeficiency virus (hiv) by antiseptics for the ora cavity' *
See also references of WO9204031A1 *
W.W.BOND ET AL. 'PROC. INT. SYMP. ON POVIDONE' 1983 , GEORGE A. DIGENIS , LEXINGTON KY. "Observations on the sporicidal, bactericidal and virucidal activity of iodophors" *

Also Published As

Publication number Publication date
AU8503791A (en) 1992-03-30
WO1992004031A1 (en) 1992-03-19
JPH05502183A (en) 1993-04-22
CA2072871A1 (en) 1992-03-05
EP0500893A1 (en) 1992-09-02
AU644216B2 (en) 1993-12-02

Similar Documents

Publication Publication Date Title
EP0500893A4 (en) Preservation of blood, tissues and biological fluids
CA2141803A1 (en) Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
YU48099A (en) Composition that involves nutrient and herb and its application
CA2129651A1 (en) Polymer blends for torque transmitting catheters
CA2400801A1 (en) Treatment of congestive heart failure by pretreated autologous blood
PL336294A1 (en) Improvement in storage and preservation of blood-derived products
GB8720704D0 (en) Hard tissue substitute composition
DE3674941D1 (en) OZONE DISINFECTION OF BLOOD AND BLOOD PRODUCTS.
ATE517628T1 (en) ANTIADHESIVE CARBOHYDRATES
AU7437494A (en) A novel physiologically active substance
ATE80548T1 (en) MEDICAL LIQUID CONTAINER AND ITS MANUFACTURE.
IT1224733B (en) BACTERIAL TREATMENT TO PRESERVE HAY QUALITY THROUGH THE ADDITION OF MICROORGANISMS OF THE GENDER BACILLUS
AU2053588A (en) Elaboration of host defense mediators into biological fluids by systemic dsrna treatment
CA2119554A1 (en) Method and compositions with aldehyde stabilizing solution
TW363887B (en) Surgical implement
CA2155557A1 (en) Process for killing soil pathogens
ES2067520T3 (en) ANTIBIOTICS AND PROCEDURE FOR ITS PRODUCTION.
CA2023823A1 (en) Method of preventing color change of food
EP0199117A3 (en) New therapeutical use of phosphocreatine
ATE415958T1 (en) COMBINATIONS OF ACTIVE INGREDIENTS EFFECTIVE AGAINST BACTERIA, MYCOTA AND VIRUSES BASED ON DIALKYL-SUBSTITUTED ACETIC ACIDS AND GLYCERINAL ALKYL ETHERS
RU93045442A (en) DEVICE FOR CHANGING THE ACTIVITY OF BIOLOGICAL CELLS
ATE128964T1 (en) APPLICATION OF BETA-ALETHINE IN CELL CULTURE AND THERAPY.
Ramakrishnan et al. The management of anaerobic infection in extensive burns
Neu Ecology, clinical significance, and antimicrobial susceptibility of Pseudomonas aeruginosa.
RU94007001A (en) SALTS 2-MORFOLIN-5-PHENYL-6N-1,3,4-TIADIAZINE AND 4,7-DIGIDRO-6-NITRO-7-OXO- / 1,2,4 / -TRIAZOLO / 5,1-С // 1,2,4 / -TRIAZINES, possessing bacterial activity with respect to mycoplasmosis agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920526

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930115

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19941222

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950704